BiomX Inc. (PHGE) Tops Q2 EPS by 16c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- S&P Global explores potential separation of Capital IQ business
- Equities end higher as Anthropic's IPO filing buoys AI stocks
H.C. Wainwright Reiterates Buy Rating on BiomX (PHGE)
August 16, 2024 2:58 PM EDTH.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating and $2.00 price target on BiomX (NYSE: PHGE).
The analyst comments "Valuation and risks to price target achievement. We reiterate our Buy rating and $2 price target. Our valuation is based on our clinical net present... More



